XML 34 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1
Segment Data (Tables)
 6 Months Ended
Mar. 31, 2017
Segment Reporting [Abstract]  
Financial Information for Company's Segments
Financial information for the Company’s segments was as follows:
 
Three Months Ended
March 31,
 
Six Months Ended
March 31,
(Millions of dollars)
2017
 
2016
 
2017
 
2016
Revenues (A)
 
 
 
 
 
 
 
Medical
$
1,987

 
$
2,131

  
$
3,951

 
$
4,185

Life Sciences
982

 
936

  
1,940

 
1,869

Total Revenues
$
2,969

 
$
3,067

 
$
5,892

 
$
6,054

Income Before Income Taxes
 
 
 
 
 
 
 
Medical
$
537

 
$
513

 
$
1,085

 
$
978

Life Sciences
177

 
202

  
376

 
404

Total Segment Operating Income
714

 
715

  
1,461

 
1,381

Acquisitions and other restructurings
(76
)
 
(104
)
 
(163
)
 
(225
)
Net interest expense
(79
)
 
(96
)
 
(169
)
 
(187
)
Other unallocated items (B)
(197
)
 
(139
)
 
(76
)
 
(328
)
Income Before Income Taxes
$
362

 
$
376

 
$
1,054

 
$
642


(A)
Intersegment revenues are not material.
(B)
Primarily comprised of foreign exchange, corporate expenses, and share-based compensation expense. The amount for the six months ended March 31, 2017 also included a $336 million reversal of certain reserves related to an appellate court decision which, among other things, reversed an unfavorable antitrust judgment in the RTI case. Additional disclosures regarding this legal matter are provided Note 5.
Revenues by Geographic Areas
Revenues by geographic areas were as follows:
 
Three Months Ended
March 31,
 
Six Months Ended
March 31,
(Millions of dollars)
2017
 
2016
 
2017
 
2016
Revenues
 
 
 
 
 
 
 
United States
$
1,627

 
$
1,719

 
$
3,257

 
$
3,410

International
1,342

 
1,349

 
2,635

 
2,644

Total Revenues
$
2,969

 
$
3,067

 
$
5,892

 
$
6,054